Doximity, Inc. Class A Common Stock (DOCS)
33.34
+0.14 (0.42%)
NYSE · Last Trade: Nov 13th, 4:36 PM EST
News & Press Releases
DOXIMITY DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 13, 2026
Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine
Doximity, the leading digital platform for U.S. medical professionals, NewYork-Presbyterian, Columbia University and Weill Cornell Medicine today announced that Doximity will provide clinical staff at all three academic healthcare institutions with additional AI-powered clinical decision support and scribe tools.
By Doximity · Via Business Wire · November 13, 2026
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via GlobeNewswire · November 12, 2026
More Than Half of U.S. Physicians Now Use AI In Their Practice Daily, But Few Have Clear Rules For It
Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, released its Doctor-Driven AI Report finding that AI has crossed a threshold in medicine: it’s a tool more than 8 in 10 rely on every week, physicians say, but adoption is outpacing the rules that govern it.
By Doximity · Via Business Wire · November 12, 2026
Doximity (NYSE:DOCS) Shares Fall on Soft Guidance and Margin Pressurechartmill.com
Via Chartmill · November 5, 2026
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
Healthcare Innovation and Technology Adoption Are Reshaping How Millions of Patients Access Medical Services
By FN Media · Via GlobeNewswire · November 11, 2026
A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift
EQNX::TICKER_START (OTCQB:AIRDF),(CSE:AIDR),(NYSE:TDOC),(NYSE:AMWL),(NYSE:HIMS),(NYSE:DOCS) EQNX::TICKER_END
Via FinancialNewsMedia · November 11, 2026
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Doximity, Inc. (NYSE: DOCS) is November 16, 2026
NEW YORK, NY - November 11, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) on behalf of investors that purchased or otherwise acquired Doximity common stock between August 8, 2024 and May 13, 2026 (the “Class Period”).
Via NewMediaWire · November 11, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS
NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · November 10, 2026
DOCS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities Lawsuit - Contact SueWallSt
Disclosure under scrutiny: the securities action challenges whether Doximity's public assurances that investors "won't find any banner ads" and that it had no e-newsletter product were adequate, while the Company allegedly relied on those very light-engagement advertising formats.
By SueWallSt · Via GlobeNewswire · November 10, 2026
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) investors of the November 16, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 10, 2026
Doximity: 3 Key Takeaways for Long-Term Investorsfool.com
Compute cost discipline, not just user growth, is what lets Doximity scale AI without eroding margins as usage climbs.
Via The Motley Fool · November 9, 2026
DOCS DEADLINE ONE WEEK AWAY: Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 9, 2026
DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class Action - Contact Levi & Korsinsky
Alert: Claims focus on alleged misrepresentations about Doximity's revenue growth and market share as the lawsuit contends that decelerating sales, contracting net income, and a shift in how pharmaceutical customers deployed advertising budgets were not disclosed to investors.
By Levi & Korsinsky, LLP · Via GlobeNewswire · November 9, 2026
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via GlobeNewswire · November 9, 2026
DOCS Deadline: Rosen Law Firm Urges Doximity, Inc. (NYSE: DOCS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026. Doximity describes itself as a “digital platform for medical professionals that combines health care news, workflow products, and clinician networking.”
By The Rosen Law Firm, P.A. · Via Business Wire · November 7, 2026
Doximity Q2 Earnings Call Highlightsmarketbeat.com
Doximity (NYSE:DOCS) reported fiscal second-quarter revenue growth of 4% and raised its full-year outlook, as expanding use of its artificial intelligence tools and improving AI cost efficiency helped the company exceed its guidance.
Revenue was $174.5 million for the quarter, while adjusted earnin
Via MarketBeat · November 7, 2026
DOCS Class Action Lead Plaintiff Deadline is November 16, 2026 - Contact Robbins LLP About Leading the Case Against Doximity, Inc.
San Diego, California--(Newsfile Corp. - November 6, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024 and May 13, 2026, inclusive (the "Class Period"). Doximity is a digital platform for medical professionals that combines health care news, workflow products, and clinician networking.
Via Newsfile · November 6, 2026
Doximity (DOCS) Q2 2027 Earnings Call Transcriptfool.com
Health system AI adoption climbed sharply, while accuracy and data security emerged as key concerns.
Via The Motley Fool · November 6, 2026
DOCS Q3 CY2026 deep dive: AI-driven product expansion meets margin compression
Medical professional network Doximity (NYSE:DOCS) reported calendar Q3 2026 (fiscal Q2 2027) results beating Wall Street’s revenue expectations, with sales u...
Via StockStory · November 6, 2026
DOCS INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 5, 2026
Doximity’s (NYSE:DOCS) Q3 CY2026 sales beat estimates but stock drops
Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 3.6% year on y...
Via StockStory · November 5, 2026
Doximity Announces Fiscal 2027 Second Quarter Financial Results
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 second quarter ended September 30, 2026.
By Doximity · Via Business Wire · November 5, 2026
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via GlobeNewswire · November 5, 2026
DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) investors of the November 16, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 5, 2026